European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.62% to 1,443.18 on the S&P Europe Select ADR Index, which is up 0.36% for the week.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and internet browser company Opera (OPRA), which rose 5.7% and 2.8% respectively. They were followed by petroleum refiner Equinor (EQNR) and medical device maker EDAP TMS (EDAP), which were up 3.8% and 3.6% respectively.
The decliners from continental Europe were led by pharmaceutical company Ascendis Pharma (ASND) and biopharmaceutical company argenx (ARGX), which were down 2.7% and 1.4% respectively. They were followed by internet ad agency Criteo (CRTO) and pharmaceutical company Novo Nordisk (NVO), which lost 1.9% and 0.7% respectively.
From the UK and Ireland, the gainers were led by cryptocurrency company Argo Blockchain (ARBK) and telecommunications operator Vodafone Group (VOD), which advanced 6.3% and 4.2% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which increased 3.2% and 1.9% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and construction materials supplier CRH (CRH), which dropped 2.4% and 2.5% respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and cruise line operator Carnival (CUK), which fell 1.9% and 0.8% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。